BOLD FUTURE BRAVE LEADERSHIP
THE FUTURE OF MEDICINE IS HERE At the University of Miami Leonard M. Miller School of Medicine—Florida’s first medical school—aspiring physicians are learning to shape the future of medicine. They are training to become health care leaders who will advance life-changing discoveries, transform patients’ lives, and combat health inequity. We are now positioned to reach unprecedented heights with the help of visionary friends and donors who will catapult our medical enterprise into a new dimension of leadership, achievement, and prestige.
EDUCATING OUR FUTURE HEALTH CARE LEADERS The Miller School is educating aspiring physicians who will shape the future of medicine and champion new discoveries. As part of our efforts to attract and retain the best and brightest prospective students—including those from under-represented communities— we are building a new state-of-theart medical education center, developing new scholarships, and enhancing NextGenMD, our innovative new curriculum. The Miller School of Medicine’s rankings have climbed from No. 52 to No. 45 among U.S. medical schools by U.S. News and World Report. Our scholarship initiative will give students the freedom to focus on their career path. Our goal to establish a scholarship endowment will provide free tuition for our most outstanding students.
REVOLUTIONIZING MEDICINE
The Miller School of Medicine is No. 1 in NIH funding in the state of Florida, and No. 40 nationwide.
Our physician-scientists are uncovering mysteries behind the world’s most complex diseases—from identifying sources of neurocognitive disorders to finding cures for cancer. These groundbreaking efforts enabled the Miller School of Medicine to emerge as Florida’s top recipient of research grants from the National Institutes of Health (NIH).
Tackling some of the world’s most vexing diseases, our Dr. John T. Macdonald Foundation Department of Human Genetics ranks second in NIH funding in the nation. World-renowned physician-scientists are making breakthroughs, including identifying the risk gene for Alzheimer’s disease and leveraging biomarkers to slow the progression of Amyotrophic Lateral Sclerosis (ALS).
PIONEERING NEW TECHNOLOGY IN MEDICAL EDUCATION AND RESEARCH Faculty at the Miller School of Medicine are focused on incorporating the latest technologies in our medical education programs. Our NextGenMD curriculum integrates new technologies, from virtual reality (VR) to patient and procedure simulations. We believe that combining high tech and high touch will be key to the future of patient care. Our students are using VR to replicate real-life scenarios, requiring them to respond in real time to changes in the patient’s status. In some projects, we are using a sophisticated eye tracking technology, which captures gaze data and allows instructors to see the simulation from the perspective of our students.
The Miller School is the first medical center nationwide to incorporate VR-simulation technology for eye surgery education.
The Michael S. Gordon Center for Simulation and Innovation in Medical Education is outfitted with computer- controlled, full-body patient simulators that allow trainees to practice their skills on a lifelike subject, without risk to actual patients.
The Evelyn F. McKnight Brain Institute is combining big data and precision medicine with the Precision Aging Network, a project that leverages technology and national partnerships to transform the way we think about the brain. The John P. Hussman Institute for Human Genomics will launch a new initiative using genomics to advance precision medicine in cancer, heart disease, Alzheimer’s disease, autism, and many other conditions.
IMPROVING HEALTH ACCESS AND EQUITY
The MIller School of Medicine serves one of the most diverse populations in the world. Our emphasis on community health equity governs our work with patients across different cultures and ethnicities, allowing us to provide exceptional treatment to those who need it most. Our students learn by caring for far more heterogenous demographics than they would at other medical schools. Our deep community connections have also provided crucial insight into treating and containing novel diseases— we were part of the front-line battle against the Zika virus in Miami, which prepared our researchers to combat COVID-19 through the rapid development and implementation of highly effective diagnostic tests, treatment options, and clinical trials. Our community programs provide hundreds of thousands of South Florida residents with access to comprehensive health services that align with their evolving needs.
For more information, please contact: Rachel Cameau (305) 243-8860 r.cameau@med.miami.edu Visit: med.miami.edu/giving